Formulation & Delivery US 2024

16 - 17 October 2024 | San Diego, CA

Enabling the swift progression of complex, alternative drug formats to market through safe, effective & targeted formulation and delivery strategies

Presentation Speaker
Overview Formulation & Drug Delivery Inhaled & Nasal Drug Delivery RNA Design & Delivery

Discover Formulation & Delivery US 2024: Enabling Effective Large & Small Molecule Product Development

Join over 450 leaders at Formulation & Delivery US 2024, bridging small and large biopharma to translate drug compounds into effective medicines with advanced formulation and delivery strategies, improving solubility, bioavailability, and stability.


Formulation & Delivery US 2024 features the 6th Annual Formulation & Delivery US Congress, 6th Annual Inhaled & Nasal Drug Delivery US Congress and 3rd Annual RNA Design & Delivery US Congress and is attended by over 450 senior level experts in San Diego to network and discuss the industry’s pressing challenges & opportunities. Expand your perspective with our comprehensive agenda, delving into diverse delivery routes, including oral, topical, injectable, and inhaled therapeutics. From updates in analytical development to alternative freeze-drying technologies and advances in RNA therapeutics, this is an event you won't want to miss.

6th Annual Formulation & Drug Delivery US Congress

Join world-leading experts in drug product development and delivery for this in-person meeting on the West Coast’s scientific hub, San Diego. You’ll learn about the latest advancements in the formulation of large and small molecule-based drugs, new modalities such as cell & gene and ADCs; and explore the innovations in the delivery of complex and challenging therapeutics.

Over 250 attendees representing global pharmaceutical organisations, leading biotech companies as well as internationally renowned academic organisations & research institutes

Over 50 case studies, presentations, panel discussions focused on the key issues in biologics, new modalities and small molecule formulation and delivery spanning topical, oral, and injectable dosage forms 

Agenda at a Glance


Day One | Track 1: Small Molecule Drug Formulation

Day One |Track 2: Biologics & New Modalities Drug Delivery

Day One | Track 3: Lyophilization, Stability & Characterization

Day Two | Track 1: Small Molecule Drug Delivery

Day Two | Track 2: Biologics & New Modalities Drug Formulation

6th Annual Inhaled & Nasal Drug Delivery US Congress

Engage with leading experts in the field of nasal and inhaled drug product development and delivery at this must-attend in-person event in San Diego. Delve into the forefront of aerosol science, dry powder inhalers, and cutting-edge formulations tailored for improved efficacy of novel modalities; and innovations across device development and connected health.

Join over 110 top-level researchers in inhalation, respiratory and nasal drug formulation & delivery science representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic and research organisations

Explore 15+ presentations and case studies across emerging trends and challenges in inhalation and nasal drug development as well as the latest innovations in aerosol characterization, particle engineering, and formulations for increased drug retention in the lungs

Agenda at a Glance


Day One | Track 4: Inhaled and Nasal Therapies: Formulation

Day Two | Track 3: Inhaled and Nasal Therapies: Delivery & Sustainable Device Development

3rd Annual RNA Design & Delivery US Congress

Gain invaluable insights into the latest developments in RNA formulation  with case-studies highlighting delivery systems for extra-hepatic delivery. The event’s in-depth sessions will discuss the latest improvements pushing the industry forward: from mRNA characterization, CMC challenges and immunogenicity through to novel delivery approaches and optimization of LNP formulation Stay at the forefront of the growing interest in technologies including mRNA vaccines, siRNA as well as antisense and RNA interference.

Network with over 110 international experts from world-renowned pharmaceutical organizations, emerging biotech companies, and globally acclaimed academic and research institutions

Over 15 presentations and engaging interactive sessions focused on the key issues in development of formulations and delivery systems for improved RNA stability, including case studies across exosomes, lipids, and nanoparticles

 

Agenda at a Glance


Day One | Track 5: RNA Design, Formulation & Development

Day Two | Track 4: RNA Delivery

 

What to Expect

380

leading pharma, biotech, & academic delegates

40
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
51
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Formulation & Delivery US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Jamie Tsung
Director, Head of DP Formulation,
Alnylam Pharmaceuticals
Joshua Ziel
Chief Operating Officer,
Aerami
Justin Cohen
Director,
Pfizer
Rachel Groppo
Director, Lead saRNA Team,
Johnson & Johnson Innovative Medicines
Robert J Duff
VP Chemistry,
Switch Therapeutics, Inc.
Sandhya Girish
VP, Clinical Pharmacology,
Gilead Sciences

All Speakers

Ash Dugar
Senior Vice President,
Dyne Therapeutics
Brad Niles
Chief Executive Officer,
ARIZ Precision Medicine
David Loynd
President and Chief Executive Officer,
EnduRx Pharmaceuticals Inc.
David M Jackson
Chief Executive Officer,
Ceria Therapeutics
Deepak Sampath
Senior Vice President, Head of Research,
Ultragenyx Gene Therapy
Evgenyi Shalaev
Executive Director, Pharmaceutical Development,
Allergan
Jacques Van Dam
VP, Medical Affairs,
Rani Therapeutics, Inc.
James Ferguson
Chief Medical Officer,
Matinas BioPharma
John Gleeson
Senior Scientist,
Merck Life Science KGaA
Julie Zhu
Scientific Director,
GSK
Liang Huang
Professor,
Oregon State University
Lynn Kirkpatrick
Chief Executive Officer,
Ensysce Pharmaceuticals
Marine Hatit
Senior Scientist,
Prime Medicine
Paul Peng
VP, Head of CMC,
Korro Bio
Peter Petrochenko
Associate Director of Regulatory Strategy,
Regeneron
Sudip Das
Professor,
Butler University
Yuchen Fan
Principal Scientist,
Genentech
Zdravka Medarova
Chief Scientific Officer,
TransCode Therapeutics, Inc.
Zhe Wu
Senior Scientist,
Janssen Pharmaceutical Companies of Johnson & Johnson

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Reimagining Cystic Fibrosis Treatment With RNA Therapeutics

A preclinical study conducted by a group of researchers at the University of Pennsylvania shows promise in treating cystic fibrosis using RNA therapeutics.

RNA beyond the liver: challenges in non-liver rna therapeutic delivery

Advancements in RNA therapeutic delivery are extending beyond liver-specific treatments, addressing complex challenges and enabling broader applications in medicine. Innovations in lipid nanoparticles, RNA interference, and artificial intelligence are key to this progress, offering potential treatments for a range of diseases and moving closer to personalized medicine. Despite remaining challenges, these developments mark significant strides towards transformative patient care.

Beyond the Needle: Exploring the Potential of an Inhaled TB Vaccine

Research efforts aim to investigate whether an inhaled version of the tuberculosis (TB) vaccine, Bacille Calmette-Guérin (BCG) is more effective than the traditional intradermal method of delivery.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Advancements in Inhaled Gene Therapy for Pulmonary Conditions

Delve into the specifics of inhaled gene therapy, its mechanisms, applications, and future prospects, it's essential to appreciate the foundational principles of gene therapy that paved the way for these advancements.

Next-Generation Cancer Treatment Shows Promising Results: CRB-701 Hits Milestones in First-In-Human Study

With ongoing dose escalation and expansion, CRB-701 holds promise as a next-generation treatment for patients battling advanced cancers.

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch